Skip to main content
Neuca S.A. logo

Neuca S.A. — Investor Relations & Filings

Ticker · NEU ISIN · PLTRFRM00018 LEI · 259400KFX90IZ97UDQ91 WAR Wholesale and retail trade
Open in API
Filings indexed 1,572 across all filing types
Latest filing 2018-02-06 Transaction in Own Shar…
Country PL Poland
Listing WAR NEU

About Neuca S.A.

https://www.neuca.pl/s/?language=en_GB

Neuca S.A. is a leader in the wholesale distribution of pharmaceuticals, operating as a comprehensive partner in the healthcare market. The company's core business involves supplying medicines to pharmacies. A key strategic principle is not owning any pharmacies, a conscious decision to avoid competing with its primary clients. Instead, the company focuses on supporting its strategic partners—independent pharmacists—by providing a range of tools and services designed to build their competitiveness and profitability. In addition to its primary distribution activities, the group is also engaged in the manufacturing of pharmaceuticals and the management of clinical trials through its specialized subsidiaries, offering a broad portfolio of services across the healthcare value chain.

Recent filings

Filing Released Lang Actions
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 98% confidence The document text explicitly states that the Management Board ('Zarząd') of NEUCA S.A. acquired its own shares ('nabyła 65 akcji własnych') for the purpose of cancellation ('w celu umorzenia'). It details the price, nominal value, and the resulting percentage of own shares held by the company (2.58% of the share capital). This action directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2018-02-06 Polish
Nabycie przychodni lekarskiej - Content (PL)
M&A Activity Classification · 99% confidence The document text describes a specific corporate action: NEUCA MED Sp. z o. o., a subsidiary of NEUCA S.A., acquired 100% of the shares in 'Twoje Centrum Medyczne' sp. z o.o. on February 2, 2018. This is a clear announcement regarding a merger, acquisition, or takeover activity. Based on the provided definitions, this falls under M&A Activity, which corresponds to the code TAR (Transaction/Merger Activity). The document is short and reports the event directly, not announcing the publication of a larger report.
2018-02-05 Polish
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 99% confidence The document text explicitly states that the company ('Spółka') acquired its own shares ('nabyła 49 akcji własnych') for the purpose of cancellation ('w celu umorzenia'). It details the price, nominal value, and the resulting percentage of own shares held. This action directly corresponds to the definition of a company buying back or repurchasing its own shares. This aligns perfectly with the 'Transaction in Own Shares' category (POS). The document length is very short (635 chars), but it is a direct report of the transaction, not an announcement of a report's publication.
2018-02-05 Polish
Wprowadzenie akcji do obrotu - Content (PL)
Share Issue/Capital Change Classification · 95% confidence The document text is very short (845 characters) and announces a decision by the Management Board of the Warsaw Stock Exchange (GPW) to admit 1,100 series L shares of NEUCA S.A. to trading, conditional upon registration by the National Securities Depository (KDPW). This is a formal regulatory announcement concerning the listing and admission of new shares to the regulated market. This action directly relates to the capital structure and the trading status of shares. While it involves shares, it is not a general share issue announcement (SHA) but a specific regulatory step for admission to trading. Given the nature of the announcement concerning the official admission/listing process, it fits best under general Regulatory Filings (RNS) as a specific regulatory action notice, or potentially Capital/Financing Update (CAP) if interpreted broadly. However, since it is a formal notice about the official admission process by the exchange and depository, RNS is the most appropriate general regulatory fallback for such specific, non-standard corporate actions that aren't dividend declarations or insider trades. It is not a full report, thus RPA is less likely than RNS for the content itself.
2018-02-02 Polish
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 99% confidence The document text explicitly states that the Management Board ('Zarząd') of NEUCA S.A. acquired its own shares ('Spółka nabyła 24 akcje własne w celu umorzenia'). It details the number of shares acquired, the price, and the resulting percentage of the share capital and voting rights held as treasury stock. This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance). The relevant code is POS.
2018-02-01 Polish
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 98% confidence The document text explicitly states that the Management Board ('Zarząd') of NEUCA S.A. acquired its own shares ('Spółka nabyła 24 akcje własne w celu umorzenia'). It details the number of shares acquired, the price, and the resulting percentage of the share capital held as treasury stock. This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance), which is classified as 'POS'. The document is short and reports a specific transaction, not an announcement of a report.
2018-01-31 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.